Novartis, Novavax tout ability to quickly whip up pandemic flu vaccines

It's flu vaccine season, and as reports of H7N9 bird flu cases rise in China, Novartis ($NVS) and Novavax ($NVAX) both say they're now able to develop new immunizations within months of a viral strain's identification and sequencing. Report

Suggested Articles

Transporting pharmaceutical products at <-60C for more than 96 hours has seemed an insurmountable challenge. TOWER’s solution has solved the problem.

The countdown to the FDA's first coronavirus vaccine hearing has begun, and new agency documents outline an agenda for the Thursday confab.

Black Americans’ confidence in COVID-19 vaccines is dropping, with only 43% saying they will get a vaccine once it's out—down 22 points since August.